The NIAGARA-2 study, officially titled ‘A Phase IIIb, Open-label, Single-arm, Global Study of Perioperative Durvalumab With Neoadjuvant ddMVAC or Gem/Cis in Patients With Muscle-invasive Bladder ...

Diagnosed with a rare childhood cancer discovered just in time, surgery, proton therapy and chemotherapy saved two-year-old Ava. Though she had to relearn many skills, she is now thriving, with very ...